Overview
Today’s scan produced 8 Continuation Breakout signals, a moderate count that signals a selective rather than aggressive trading day. Average RVOL across the list sits near 1.0, with only GKOS (1.7) and MU (1.2) showing genuine volume conviction — the rest are drifting on below-average participation, which is typical in a Bearish regime where breadth is thin (only 22.4% of stocks above SMA-40).
Sector-wise, signals cluster around Medical/Health Care and Computer/Chips names — both top-performing sectors by ATR% today (Technology 1.8%, Health Care 1.3%), which aligns favorably with the broader regime data. This is a case of theme concentration in leading sectors rather than broad market strength, a constructive sign even as the overall tape stays defensive.
Quality Score: 3/5. Per regime rules, the Bearish/Correction environment caps upside conviction, but institutional backing is unusually strong across several names (LLY: 6,678 funds, MU: 6,325 funds), which keeps today’s setups above a baseline “quiet day” rating.
Top 5 Picks
GKOS ($172.18) — Medical / Medical-Products
GKOS leads today’s RVOL at 1.7 with a strong 6.5% move, pressing directly into a tight 1h supply zone (172.85–174.13, strength 7.1). A clean break above this zone confirms continuation, with the 4h demand zone (161.54–164.26, strength 4.8) well below as structural support.
| Entry | Stop | Target |
|---|---|---|
| $174.20 | $171.50 | $191.74 (52W High) |
Institutional Backing: 645 funds, Bucket B0/B1 — solid mid-tier sponsorship.
MU ($1088.00) — Computer / Computer-Hardware
MU sits directly at a 30m demand zone (1059.25–1073.88, strength 6.7) after a 4.1% push higher on RVOL 1.2 and a hot ATR%-M of 3.0 — strong intraday expansion. No overhead supply zone is registered, giving this breakout clean air toward prior highs.
| Entry | Stop | Target |
|---|---|---|
| $1,090.00 | $1,055.00 | $1,254.90 (52W High) |
Institutional Backing: 6,325 funds, Bucket B1/B2 — among the strongest sponsorship in today’s list.
LLY ($1188.72) — Medical / Pharmaceuticals
LLY trades between demand (1088.66–1134, strength 6.4) and supply (1233.57–1257.66, strength 7.0) on a 2.7% move. While RVOL is flat at 1.0, the mega-cap institutional base and Health Care’s sector leadership (ATR% 1.3%) support a measured continuation toward the supply band.
| Entry | Stop | Target |
|---|---|---|
| $1,195.00 | $1,130.00 | $1,233.57 |
Institutional Backing: 6,678 funds, Bucket B1 — the heaviest sponsorship in today’s scan.
SMCI ($44.94) — Computer / Computer-Hardware
SMCI shows the day’s hottest ATR%-M reading (4.0) with a 3.4% gain, trading between a 4h demand zone (40.75–41.91, strength 7.5) and a monthly supply ceiling (47.57–58.78, strength 6.9). Volatility expansion plus sector tailwinds in Computer/Chips make this a high-ADR (5.2%) continuation candidate.
| Entry | Stop | Target |
|---|---|---|
| $45.20 | $43.00 | $47.57 / $58.78 |
Institutional Backing: 1,598 funds, Bucket B1/B2 — healthy institutional presence.
AMGN ($413.08) — Medical / Profitable Biotech
AMGN is pressing a daily supply zone (421.51–426.59, strength 6.6) after a 2.6% gain. RVOL is light (0.7), but deep institutional backing and Health Care’s sector strength offer a reasonable continuation thesis on a confirmed breakout above supply.
| Entry | Stop | Target |
|---|---|---|
| $427.00 | $418.00 | $447.05 (52W High) |
Institutional Backing: 3,898 funds — strong biotech sponsorship.
Honorable Mentions
ENTG ($166.32) — Chips sector supply test, but negative change (-0.3%) weakens conviction.
SN ($185.19) — Consumer name at supply with solid institutional base (1,117 funds), but RVOL only 0.7.
FIP ($2.84) — Small-cap Transportation mover (+6.4%) with high ADR (7.0%) but thin institutional support (205 funds) and elevated risk.
Strategy Summary
Today’s continuation setups are moderate quality (3/5), appropriately capped by the Bearish regime despite pockets of strong institutional sponsorship and volume. The clearest edge lies in Medical/Health Care and Computer/Chips names — both top-ranked sectors by ATR% — where MU, GKOS, and LLY offer the best combination of volume confirmation and fund backing. Position sizing should remain conservative given thin market breadth (22.4% above SMA-40); favor tighter stops near zone boundaries and take partial profits at first supply targets rather than holding for extended 52-week-high runs.